◀ Back to TP53

MED1 — TP53

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

• IRef Biogrid Interaction: MED1 — TP53 (physical association, affinity chromatography technology) Lottin-Divoux et al., FEBS Lett 2005*
• IRef Biogrid Interaction: MED1 — TP53 (physical association, affinity chromatography technology) Frade et al., Cancer Res 2000*
• IRef Biogrid Interaction: MED1 — TP53 (direct interaction, pull down) Drané et al., Oncogene 1997*
• IRef Dip Interaction: MED1 — TP53 (physical association, coimmunoprecipitation) Frade et al., Cancer Res 2000*
• IRef Dip Interaction: MED1 — TP53 (physical association, affinity chromatography technology) Drané et al., Oncogene 1997*
• IRef Intact Interaction: MED1 — TP53 (physical association, anti bait coimmunoprecipitation) Lottin-Divoux et al., FEBS Lett 2005*
• IRef Intact Interaction: MED1 — TP53 (physical association, pull down) Lottin-Divoux et al., FEBS Lett 2005*
• IRef Ophid Interaction: MED1 — TP53 (aggregation, interologs mapping) Brown et al., Bioinformatics 2005

Text-mined interactions from Literome

Radhakrishnan et al., Cancer Res 2006 (Neoplasms...) : Although ARC promoted the accumulation of p53 , ARC induced apoptosis in tumor cells was p53 independent, suggesting that it may be useful for the treatment of tumors with functionally inactive p53
Li et al., Aging Cell 2007 : Aging up-regulated expression of Bax, Bcl2 and ARC , down-regulated XIAP expression and did not affect p53 , pp53 and Omi/HtrA2